Literature DB >> 22311380

New perspectives in melatonin uses.

A Carpentieri1, G Díaz de Barboza, V Areco, M Peralta López, N Tolosa de Talamoni.   

Abstract

This review summarizes the metabolism, secretion, regulation and sites of action of melatonin. An updated description of the melatonin receptors, including their signal transduction mechanisms, distribution and characterization of receptor genes, is given. Special emphasis is focused on the clinical aspects and potential uses of melatonin in the sleep-wake rhythms, in the immune function, in cancer therapy, in neuroprotection against oxidative damage and antioxidant activities in different tissues. Finally, combined effects of melatonin with other drugs are discussed.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311380     DOI: 10.1016/j.phrs.2012.01.003

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  34 in total

1.  The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Authors:  Marissa Giovanna Schamne; Josiel Mileno Mack; Morgana Moretti; Filipe Carvalho Matheus; Roger Walz; Laurence Lanfumey; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2018-05-28       Impact factor: 3.911

Review 2.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

3.  Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.

Authors:  Gorka Gerenu; Kai Liu; Jeremy E Chojnacki; John M Saathoff; Pablo Martínez-Martín; George Perry; Xiongwei Zhu; Hyoung-Gon Lee; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2015-05-04       Impact factor: 4.418

Review 4.  Neuroendocrine control of photoperiodic changes in immune function.

Authors:  Zachary M Weil; Jeremy C Borniger; Yasmine M Cisse; Bachir A Abi Salloum; Randy J Nelson
Journal:  Front Neuroendocrinol       Date:  2014-10-18       Impact factor: 8.606

5.  Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls

Authors:  Philipp Ritter; Falk Wieland; Debra J. Skene; Andrea Pfennig; Maria Weiss; Michael Bauer; Emanuel Severus; Henry Güldner; Cathrin Sauer; Bettina Soltmann; Stefanie Neumann
Journal:  J Psychiatry Neurosci       Date:  2020-03-01       Impact factor: 6.186

6.  Antioxidant and antiapoptotic properties of melatonin restore intestinal calcium absorption altered by menadione.

Authors:  A Carpentieri; A Marchionatti; V Areco; A Perez; V Centeno; N Tolosa de Talamoni
Journal:  Mol Cell Biochem       Date:  2013-11-15       Impact factor: 3.396

7.  Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.

Authors:  Agata Zemła; Irmina Grzegorek; Piotr Dzięgiel; Karolina Jabłońska
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

8.  Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin.

Authors:  Jeremy E Chojnacki; Kai Liu; Xing Yan; Stefano Toldo; Tyler Selden; Martin Estrada; María Isabel Rodríguez-Franco; Matthew S Halquist; Dexian Ye; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2014-05-22       Impact factor: 4.418

Review 9.  Melatonin in perioperative medicine: Current perspective.

Authors:  Souvik Maitra; Dalim Kumar Baidya; Puneet Khanna
Journal:  Saudi J Anaesth       Date:  2013-07

10.  The Angiotensin-melatonin axis.

Authors:  Luciana A Campos; Jose Cipolla-Neto; Fernanda G Amaral; Lisete C Michelini; Michael Bader; Ovidiu C Baltatu
Journal:  Int J Hypertens       Date:  2013-01-08       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.